Publications by authors named "E Montero-Hernandez"

This document provides a comprehensive analysis of the use of point-of-care ultrasound in heart failure (HF), offering detailed recommendations on echocardiography, lung ultrasound, and venous ultrasound. These advanced imaging techniques allow for an accurate, detailed, and non-invasive evaluation of heart failure, facilitating rapid and effective clinical decision-making. Echocardiography enables a rapid assessment of cardiac function at the point of care, enhancing traditional physical examination and being essential for the management of heart failure (HF).

View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted to evaluate the effectiveness of combining hypertonic saline solution (HSS) with furosemide in treating patients with worsening heart failure, focusing on potential improvements in diuretic response in an outpatient setting.
  • The results showed no significant difference in short-term diuresis or natriuresis between the two treatment groups; however, the Furosemide-HSS group had slightly decreased weight after 7 days.
  • Overall, the combination therapy did not lead to better outcomes in terms of congestion or kidney function compared to furosemide alone, suggesting it may not be beneficial in this context.
View Article and Find Full Text PDF

Aims: Hypertonic saline solution (HSS) plus intravenous (IV) loop diuretic appears to enhance the diuretic response in patients hospitalized for heart failure (HF). The efficacy and safety of this therapy in the ambulatory setting have not been evaluated. We aimed to describe the design and baseline characteristics of the SALT-HF trial participants.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the relationship between COVID-19 and heart failure (HF), focusing on identifying risk factors for HF among hospitalized COVID-19 patients in Spain.
  • - A total of 16,474 patients were analyzed, with 5.8% developing HF; significant risk factors included older age, atrial fibrillation, obesity, and peripheral vascular disease.
  • - Patients who developed HF had notably higher mortality rates, increased need for intubation, and higher ICU admission rates compared to those who did not develop HF.
View Article and Find Full Text PDF

Introduction And Objectives: Patients with combined heart failure (HF) and chronic kidney disease (CKD) have been underrepresented in clinical trials. The prevalence of CKD in these patients and their clinical profile require constant evaluation. This study aimed to analyze the prevalence of CKD, its clinical profile, and patterns of use of evidence-based medical therapies in HF across CKD stages in a contemporary cohort of ambulatory patients with HF.

View Article and Find Full Text PDF